NDAORALTABLET
Lifecycle
Pre-Launch
Clinical Trials
17
Data completeness
3/8 — Basic
HALDOL SOLUTAB (haloperidol) by Johnson & Johnson is clinical pharmacology the precise mechanism of action has not been clearly established. Approved for schizophrenia, bipolar disorder.
Drug data last refreshed 2w ago
Mechanism of Action
CLINICAL PHARMACOLOGY The precise mechanism of action has not been clearly established.
Indications (2)
Clinical Trials (17)
IM Olanzapine Versus Haloperidol or Midazolam
Started Dec 2014
167 enrolled
Acute Agitation, Behavioural Emergency
Pragmatic RCT Comparing Aripiprazole, Olanzapine and Haloperidol in the Treatment of Schizophrenia
Started Jul 2007
300 enrolled
Schizophrenia
Randomized Evaluation of the Effectiveness of Clozapine and Aripiprazole Versus Clozapine and Haloperidol in the Treatment of Schizophrenia
Started Sep 2006
106 enrolled
Schizophrenia
A Comparison Study of the Efficacy of Quetiapine and Haloperidol in Agitated Adults in Emergency Room
Started May 2006
72 enrolled
Agitation
Pilot Study of Haloperidol to Treat Critical Illness Delirium
Started Dec 2005
20 enrolled
DeliriumCritical Illness
Worked on HALDOL SOLUTAB at Johnson & Johnson? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.